Oxford BioTheraputics Names Abderrahim Fandi as CMO

Abderrahim Fandi, formerly of Celgene, has joined Oxford BioTherapeutics as the company’s CMO. His position will be responsible for developing OBT’s immuno-oncology candidates.

Rahim brings a wealth of drug development expertise to OBT, which will significantly benefit the company as we move our clinical development program forward in the United States for MEN1309, our novel ADC therapy [that’s] currently undergoing clinical testing in Europe,” said OBT CEO Christian Rohlff in a recent statement.[1]

The press release announces that Dr. Fandi has led the development of several oncology compounds and participated in successful regulatory interactions, including many with the FDA. He has also held positions at Novartis, BMS, AstraZeneca, and Sanofi Aventis, and has contributed to over 100 peer-reviewed publications and abstracts. In addition, he has served as first author in lead journals, including the Journal of Clinical Oncology.

To read the full press release from Oxford BioTherapeutics, visit PharmiWeb.com.


[1] https://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=267248

Follow us on social media for the latest updates in B2B!


Grocery Store Prepared Meals
Consumers Want More Grocery Store Prepared Meals. How Should Grocers Adapt?
December 6, 2022

The consumer dollar has spoken: the best thing since sliced bread is sliced turkey. A new FMI report, the FMI Power of Foodservice at Retail, seems to show that deli-prepared food purchases are up 9.3% compared to 2019 numbers and up 2.4% year-over-year in unit sales. It’s clear that consumer appetite for grocery store prepared […]

Read More
Robotics in Early Learning Can Be Essential in How Students React to STEM Literacy
December 6, 2022

Early learning robotics can be essential in how students react to STEM literacy and with large gaps In STEM achievement persisting across the U.S., access to technological resources can make a significant impact. K-12 education was disrupted by the COVID-19 pandemic, but the disruption could be mitigated by introducing the latest and innovative technology into […]

Read More
The European Space Agency Lunar Launch Programs and Service Initiatives to Watch in 2023
December 6, 2022

The European Space Agency is making strides in its efforts to commercialize space, with a focus on sustained exploration. What are they doing to achieve this? According to the ESA, it all starts with service initiatives. A recent panel discussion at the Space Tech Expo in Bremen, Germany revealed that the ESA is growing its […]

Read More